Azenta (STU:BA3) Cyclically Adjusted Revenue per Share: €8.46 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:BA3 Azenta Inc STU:BA3
78 GF Score
Price €28.20
GF Value €45.97
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Azenta Cyclically Adjusted Revenue per Share?

Azenta STU:BA3 -1.40% 78 Cyclically Adjusted Revenue per Share is €8.46 as of Jun. 2026. GuruFocus rates STU:BA3 with a GF Score™ of 78/100 and a GF Value™ of €45.97 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Azenta's adjusted revenue per share for the three months ended in Jun. 2026 was €3.089. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €8.46 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Azenta's average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Azenta was 4.40% per year. The lowest was -9.30% per year. And the median was -1.80% per year.

As of today (2026-08-29), Azenta's current stock price is €28.20. Azenta's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €8.46. Azenta's Cyclically Adjusted PS Ratio of today is 3.33.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Azenta was 15.86. The lowest was 1.44. And the median was 4.78.


Azenta  (STU:BA3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Azenta's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=28.20/8.46
=3.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Azenta was 15.86. The lowest was 1.44. And the median was 4.78.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Azenta Cyclically Adjusted Revenue per Share Related Terms


Azenta Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Azenta's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Azenta Cyclically Adjusted Revenue per Share Chart

Azenta Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.70 8.40 7.89 7.78 7.68

Azenta Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.62 7.68 8.19 8.18 8.46

STU:BA3 vs KMTS, STAA, BLFS: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Azenta's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azenta Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Azenta's Cyclically Adjusted PS Ratio falls into.


STU:BA3
78GF Score
Azenta Inc STU:BA3
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Azenta Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Azenta's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.089/333.9520*333.9520
=3.089

Current CPI (Jun. 2026) = 333.9520.

Azenta Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.405 241.428 0.560
201612 2.170 241.432 3.002
201703 2.257 243.801 3.092
201706 2.297 244.955 3.132
201709 0.194 246.819 0.262
201712 1.700 246.524 2.303
201803 1.803 249.554 2.413
201806 2.079 251.989 2.755
201809 1.928 252.439 2.551
201812 2.185 251.233 2.904
201903 2.429 254.202 3.191
201906 2.490 256.143 3.246
201909 -3.095 256.759 -4.025
201912 2.572 256.974 3.342
202003 2.701 258.115 3.495
202006 2.649 257.797 3.432
202009 -3.008 260.280 -3.859
202012 1.307 260.474 1.676
202103 1.465 264.877 1.847
202106 1.442 271.696 1.772
202109 1.547 274.310 1.883
202112 1.651 278.802 1.978
202203 1.763 287.504 2.048
202206 1.674 296.311 1.887
202209 1.854 296.808 2.086
202212 2.321 296.797 2.612
202303 2.006 301.836 2.219
202306 2.415 305.109 2.643
202309 0.925 307.789 1.004
202312 2.292 306.746 2.495
202403 2.263 312.332 2.420
202406 2.531 314.175 2.690
202409 2.838 315.301 3.006
202412 3.086 315.605 3.265
202503 2.899 319.799 3.027
202506 2.724 322.561 2.820
202509 2.920 324.800 3.002
202512 2.764 324.054 2.848
202603 2.719 330.213 2.750
202606 3.089 333.952 3.089

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €8.46 mean?
Azenta (STU:BA3) has a Cyclically Adjusted Revenue per Share of €8.46 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Azenta and its competitors.
Is Azenta's Cyclically Adjusted Revenue per Share too high?
Azenta's current Cyclically Adjusted Revenue per Share is €8.46. Overall, Azenta has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azenta's Cyclically Adjusted Revenue per Share compare to KMTS and STAA?
Azenta's Cyclically Adjusted Revenue per Share of €8.46 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Azenta and its competitors. Azenta's current Cyclically Adjusted Revenue per Share is €8.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azenta stock overvalued right now?
Based on GuruFocus' analysis, Azenta (STU:BA3) is currently considered Significantly Undervalued. The stock's GF Value™ is €45.97, compared to a current price of €28.20 — trading 38.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €8.46. Azenta's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Azenta (STU:BA3), the current Cyclically Adjusted Revenue per Share is €8.46 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Azenta (STU:BA3) Overvalued in 2026?

Based on GuruFocus' analysis, Azenta stock appears to be undervalued. The current stock price of €28.20 is trading 38.7% below its estimated GF Value™ of €45.97. GuruFocus considers Azenta to be Significantly Undervalued.

Key valuation signals for STU:BA3:

  • Cyclically Adjusted Revenue per Share: €8.46
  • GF Value™: €45.97 vs. price of €28.20 (38.7% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the STU:BA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Azenta Business Description

Other Exchanges AZTA:USA0HQ1:UK
Address 200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
78GF Score

Get the complete analysis for STU:BA3

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.20
Price
€45.97
GF Value